177 related articles for article (PubMed ID: 29500549)
1. Study on the Mechanisms of Active Compounds in Traditional Chinese Medicine for the Treatment of Influenza Virus by Virtual Screening.
Ai H; Wu X; Qi M; Zhang L; Hu H; Zhao Q; Zhao J; Liu H
Interdiscip Sci; 2018 Jun; 10(2):320-328. PubMed ID: 29500549
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel compounds against an R294K substitution of influenza A (H7N9) virus using ensemble based drug virtual screening.
Tran N; Van T; Nguyen H; Le L
Int J Med Sci; 2015; 12(2):163-76. PubMed ID: 25589893
[TBL] [Abstract][Full Text] [Related]
3. Screening and evaluation of commonly-used anti-influenza Chinese herbal medicines based on anti-neuraminidase activity.
Han X; Zhang DK; Guo YM; Feng WW; Dong Q; Zhang CE; Zhou YF; Liu Y; Wang JB; Zhao YL; Xiao XH; Yang M
Chin J Nat Med; 2016 Oct; 14(10):794-800. PubMed ID: 28236410
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
5. Herbal Medicines with Antiviral Activity Against the Influenza Virus, a Systematic Review.
Lee JY; Abundo MEC; Lee CW
Am J Chin Med; 2018; 46(8):1663-1700. PubMed ID: 30612461
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation.
Jin Z; Wang Y; Yu XF; Tan QQ; Liang SS; Li T; Zhang H; Shaw PC; Wang J; Hu C
Comput Biol Chem; 2020 Apr; 85():107241. PubMed ID: 32120300
[TBL] [Abstract][Full Text] [Related]
7. Computational screen and experimental validation of anti-influenza effects of quercetin and chlorogenic acid from traditional Chinese medicine.
Liu Z; Zhao J; Li W; Shen L; Huang S; Tang J; Duan J; Fang F; Huang Y; Chang H; Chen Z; Zhang R
Sci Rep; 2016 Jan; 6():19095. PubMed ID: 26754609
[TBL] [Abstract][Full Text] [Related]
8. Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.
Mathew S; Al Thani AA; Yassine HM
PLoS One; 2018; 13(9):e0203148. PubMed ID: 30180218
[TBL] [Abstract][Full Text] [Related]
9. Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines.
Liu J; Zu M; Chen K; Gao L; Min H; Zhuo W; Chen W; Liu A
BMC Complement Altern Med; 2018 Mar; 18(1):102. PubMed ID: 29558938
[TBL] [Abstract][Full Text] [Related]
10. Progress of small molecular inhibitors in the development of anti-influenza virus agents.
Wu X; Wu X; Sun Q; Zhang C; Yang S; Li L; Jia Z
Theranostics; 2017; 7(4):826-845. PubMed ID: 28382157
[TBL] [Abstract][Full Text] [Related]
11. [Screening based on response surface methodology of multi-fractions traditional Chinese medicine with anti-influenza virus neuraminidase activity: take shuanghuanglian injection as an example].
Qiu LL; Chen LH; Yan D; Zhang P; Tan MR; Li ZM; Xiao XH
Yao Xue Xue Bao; 2012 Apr; 47(4):466-71. PubMed ID: 22799028
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Chinese traditional patent medicines against influenza virus in vitro].
Zu M; Zhou D; Gao L; Liu AL; Du GH
Yao Xue Xue Bao; 2010 Mar; 45(3):408-12. PubMed ID: 21351522
[TBL] [Abstract][Full Text] [Related]
13. Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approaches.
Gu S; Yin N; Pei J; Lai L
Mol Biosyst; 2013 Nov; 9(11):2696-700. PubMed ID: 23986228
[TBL] [Abstract][Full Text] [Related]
14. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
Chang SS; Huang HJ; Chen CY
Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Eichelberger MC; Hassantoufighi A; Wu M; Li M
Virol J; 2008 Sep; 5():109. PubMed ID: 18822145
[TBL] [Abstract][Full Text] [Related]
16. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
Gasparini R; Amicizia D; Lai PL; Bragazzi NL; Panatto D
J Prev Med Hyg; 2014 Dec; 55(4):109-29. PubMed ID: 26137785
[TBL] [Abstract][Full Text] [Related]
17. Ching-fang-pai-tu-san inhibits the release of influenza virus.
Hsieh CF; Yen HR; Liu CH; Lin S; Horng JT
J Ethnopharmacol; 2012 Dec; 144(3):533-44. PubMed ID: 23041224
[TBL] [Abstract][Full Text] [Related]
18. Discovery of natural multi-targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment.
Cao L; Liu Y; Ma B; Yi B; Sun J
Chem Biol Drug Des; 2024 Jan; 103(1):e14359. PubMed ID: 37743355
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach.
Karthick V; Ramanathan K; Shanthi V; Rajasekaran R
Cell Biochem Biophys; 2013 Jul; 66(3):657-69. PubMed ID: 23306969
[TBL] [Abstract][Full Text] [Related]
20. Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein.
Ahmad A; Javed MR; Rao AQ; Husnain T
BMC Complement Altern Med; 2016 Dec; 16(1):519. PubMed ID: 27986088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
